Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
1 trials
Recent
Start date
Enrollment
Gastro-enteropancreatic neuroendocrine tumor
×
Everolimus
×
90 days
×
Clear all
Filters
3
NCT05477576
2026-01-20
ACTION-1
RayzeBio, Inc.
Phase 3
Recruiting
288 enrolled